SNOA logo

Sonoma Pharmaceuticals (SNOA)

Profile

Full Name

Sonoma Pharmaceuticals, Inc.

Ticker Symbol

SNOA

Exchange

NASDAQ

Country

United States

IPO

January 25, 2007

Indexes

Not included

Employees

10

Key Details

Price

$2.36(-9.23%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$12.73M(-4.05% YoY)

Annual EPS

-$10.60(+65.13% YoY)

PE ratio

-

Next earnings date

Jun 17, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Sep 5, 23 Ladenburg Thalmann
Buy
Nov 25, 20 Maxim Group
Buy
Nov 25, 20 Benchmark
Speculative Buy
Mar 6, 18 Maxim Group
Hold
Dec 28, 17 Benchmark
Speculative Buy
Nov 10, 17 Maxim Group
Buy

Institutional Ownership

  • What is the ticker symbol for Sonoma Pharmaceuticals?
  • Does Sonoma Pharmaceuticals pay dividends?
  • What sector is Sonoma Pharmaceuticals in?
  • What industry is Sonoma Pharmaceuticals in?
  • What country is Sonoma Pharmaceuticals based in?
  • When did Sonoma Pharmaceuticals go public?
  • Is Sonoma Pharmaceuticals in the S&P 500?
  • Is Sonoma Pharmaceuticals in the NASDAQ 100?
  • Is Sonoma Pharmaceuticals in the Dow Jones?
  • When was Sonoma Pharmaceuticals's last earnings report?
  • When does Sonoma Pharmaceuticals report earnings?
  • Should I buy Sonoma Pharmaceuticals stock now?

What is the ticker symbol for Sonoma Pharmaceuticals?

The ticker symbol for Sonoma Pharmaceuticals is NASDAQ:SNOA

Does Sonoma Pharmaceuticals pay dividends?

No, Sonoma Pharmaceuticals does not pay dividends

What sector is Sonoma Pharmaceuticals in?

Sonoma Pharmaceuticals is in the Healthcare sector

What industry is Sonoma Pharmaceuticals in?

Sonoma Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Sonoma Pharmaceuticals based in?

Sonoma Pharmaceuticals is headquartered in United States

When did Sonoma Pharmaceuticals go public?

Sonoma Pharmaceuticals's initial public offering (IPO) was on January 25, 2007

Is Sonoma Pharmaceuticals in the S&P 500?

No, Sonoma Pharmaceuticals is not included in the S&P 500 index

Is Sonoma Pharmaceuticals in the NASDAQ 100?

No, Sonoma Pharmaceuticals is not included in the NASDAQ 100 index

Is Sonoma Pharmaceuticals in the Dow Jones?

No, Sonoma Pharmaceuticals is not included in the Dow Jones index

When was Sonoma Pharmaceuticals's last earnings report?

Sonoma Pharmaceuticals's most recent earnings report was on Feb 5, 2025

When does Sonoma Pharmaceuticals report earnings?

The next expected earnings date for Sonoma Pharmaceuticals is Jun 17, 2025

Should I buy Sonoma Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page